Press Release

CB-022-MS An ISO 9001 : 2015 Company bHANsAli ENGiNEERiNq polyMERs liMiTEd CIN : L271OOMH1984PLC032637 Registered Office : 301 & 302, 3rd Floor, Peninsula Heights, C. D. Barfiwala Road, Andheri (West}, Mumbai -400 058. Tel. : (91-22} 2621 6060/61/62/63/64 •E-mail: abstron@bhansaliabs.com •Website : www.bhansaliabs.com BEPL/SEC/2026/224 18th July, 2026 To, To, BSE Limited, The National Stock Exchange of India Ltd., Corporate Relationship Department, Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers, Sandra Kurla Complex, Dalal Street, Mumbai - 400 001 Sandra (East), Mumbai - 400 001 Security Code: 500052 Security Code: BEPL Sub: Press Release for the Quarter ended 30th June 2026. Dear Sir /Madam, Please find attached Press Release issued in relation to the Un-audited (Standalone and Consolidated) Financial Results of the Company, for the quarter ended 30th June, 2026. Kindly take the same on record. Thanking you, Yours faithfully, For Bhansali Engineering Polymers Limited Ashwin M. Patel Company Secretary and GM (Legal) Encl: As above Satnoor Plant : Bhansali Nagar, Taluka -Sausar, Dist. Chhindwara, Madhya Pradesh -480 108. Tel. : (07165) 226376/77/78/79 •E-mail : beplchw@bhansaliabs.com Abu Road Plant : Plot No. SP-138-143, Ambaji Industrial Area, Abu Road, Dist. Sirohi (Rajasthan) -307 026. Tel. : (02974) 226781/82/83/84 •E-mail: beplabr@bhansaliabs.com BEPL NSE: BEPL | BSE: 500052 | CIN: L27100MH1984PLC032637 PRESS RELEASE Bhansali Engineering Polymers Delivers Strong Q1 FY27 Results EBITDA up 48.4% and PAT up 41.3% YoY in Q1 FY26; ₹200 crores debottlenecking capex fully funded through internal accruals Mumbai, India | July 18, 2026 KEY HIGHLIGHTS Q1 FY27 Performance and Business Update Particulars Q1 FY27 Q1 FY26 YoY Total Income ₹ 341.6 Crores ₹ 307.9 Crores +8.7% EBITDA* ₹ 74.3 Crores ₹ 63.9 Crores +1.3% EBITDA Margin* 21.8% 20.9% +50 bps Profit After Tax ₹ 51.6 Crores ₹ 45.9 Crores +0.1% Profit After Tax Margin 15.1% 14.9% +54.6% *Includes Other Income Financial & Operational Highlights ▪ Revenue growth was driven by higher realizations, while operating leverage and improved cost efficiencies contributedtoasignificantexpansioninprofitability. ▪ EBITDAincreasedto₹ 76crores inQ1 FY27from₹ 53crores inQ1 FY 26, withthe EBITDA margin improving toxx%fromxx%. ▪ PAT margin expanded to 15.1% in Q1 FY27 from 14.9% in the corresponding quarter last year, reflecting sustainedoperationaldisciplineandefficientcostmanagement. ▪ ₹200crorescapexfullyfundedthroughinternalaccruals—companyremainsdebt-free. ▪ Declaredfirstinterimdividendof₹24.9crores,reflectingcontinuedcommitmenttoshareholder returns. Registered Office : 301 & 302, 3rd Floor, Peninsula Heights, C. D. BarfiwalaRoad, Andheri (West), Mumbai -400 058. 1 Tel. : (91-22) 2621 6060/61/62/63/64 •E-mail : abstron@bhansaliabs.com•Website: www.bhansaliabs.com BEPL NSE: BEPL | BSE: 500052 | CIN: L27100MH1984PLC032637 Management Commentary Our Q1 FY27 performance underscores the resilience of our business model and the strength of our cost leadership amidst a dynamic global geopolitical environment. Despite external uncertainties, disciplined executionandsustainedoperatingefficienciesenabledustodeliverhealthygrowthinprofitability. Ourongoingcapacityexpansionto100,000MTPA,beingfundedentirelythroughinternalaccruals,reflects the robust cash-generating ability of the business while preserving ourdebt-free balance sheet. Even after thedividendpayout,thecompanycontinuestomaintainastrongcashposition,providingadequatefinancial flexibility to fund the planned ₹200 crores capital expenditure, support the incremental working capital requirements arising from the expanded capacity, and maintain a prudent liquidity buffer to navigate Mr.JayeshB.Bhansali potentialmacroeconomicandgeopoliticaluncertainties. JointManagingDirector &ChiefFinancialOfficer, The Company remains committed to delivering consistent value to its shareholders through a disciplined BEPL capitalallocationapproach.Inlinewiththiscommitment,theBoardhasdeclaredafirstinterimdividendof ₹24.9 crores for Q1 FY27, reflecting the Company's strong financial position while continuing to retain sufficientliquiditytofundfuturegrowthinitiatives. This balanced approach to capital allocation positions the Company to capitalize on the growingdomestic demandforABSandspecialtypolymerswhilecreatingsustainablelong-termshareholdervalue. CAPACITY EXPANSION UPDATE Debottlenecking Project at Abu Road Plant - Progress 75,000 MTPA 1,00,000 MTPA ₹200 Crores Current Capacity Target Total Capex Outlay 100% September 2026 FY28 Funded via Internal Accruals Targeted Commissioning Optimal Utilisation Expected Why ItMatters ▪ Strengthens BEPL'spositionasoneofIndia'slowest-costABSproducers,aheadofrisingdomesticdemand. ▪ Capacity is being added without diluting the balance sheet — funded entirely by internal accruals, keeping the companydebt-free. ▪ PositionsBEPLtocapturealargershareofthe~30-40%ofIndia'sABSdemandcurrentlymetthroughimports. ▪ ComplementsongoingR&Dandproduct-mixupgradestowardhigher-margin specialtyandcolourgrades. Registered Office : 301 & 302, 3rd Floor, Peninsula Heights, C. D. BarfiwalaRoad, Andheri (West), Mumbai -400 058. Tel. : (91-22) 2621 6060/61/62/63/64 •E-mail : abstron@bhansaliabs.com•Website: www.bhansaliabs.com BEPL NSE: BEPL | BSE: 500052 | CIN: L27100MH1984PLC032637 AboutBhansaliEngineering PolymersLimited BEPL is India's leading manufacturer of Acrylonitrile Butadiene Styrene (ABS) and Styrenic Resins, with a legacy since 1984. The Company operates manufacturing facilities at Abu Road (Rajasthan) and Satnoor (Madhya Pradesh), supported by an in-house R&D centre, and maintains a strategic joint venture with Nippon A&L Inc., Japan. BEPL's diversifiedportfolioservestheautomobile,consumerdurables,electronics,healthcare,andkitchenwareindustries. 2 75,000+ 80+ 404+ State-of-the-artFacilities MTPAInstalledCapacity VariantsofABS&SpecialtyPolymers Employees Registered Office : 301 & 302, 3rd Floor, Peninsula Heights, C. D. BarfiwalaRoad, Andheri (West), Mumbai -400 058. Tel. : (91-22) 2621 6060/61/62/63/64 •E-mail : abstron@bhansaliabs.com•Website: www.bhansaliabs.com